Abstract :
[en] In recent years, fused deposition modeling has become one of the most used threedimensional
printing technologies in the pharmaceutical field. The production of personalized
dosage forms for individualized therapy and the modification of the drug release profile by
the elaboration of complex geometries make fused deposition modeling a promising tool for
small-scale production. However, fused deposition modeling has a considerable number of
challenges to overcome. They are divided into three categories of parameters. Materialspecific
parameters encompass the physicochemical properties of the filament, like
thermal, mechanical and rheological properties. They determine the feasibility of the printing
process. Operation-specific parameters relate to the processing conditions of printing,
such as printing temperature and infill density, which have an influence on the final quality
and on the dissolution behavior of the objects. The printer equipment is defined by the
machine-specific parameters. Some modifications of this equipment also enhance the
performance of the printing process. The aim of this review is to highlight the major fused
deposition modeling critical process parameters in the pharmaceutical field and possible
solutions in order to speed up the development of objects in the pharmaceutical market.
Name of the research project :
Development of new oral formulations produced by the hot melt extrusion technique coupled with 3D printing in order to increase the solubility of active molecules like BCSII
Scopus citations®
without self-citations
95